Westover Capital Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.36M Buy
3,656
+1,585
+77% +$1.61M 0.62% 40
2025
Q4
$2.23M Buy
2,071
+187
+10% +$179K 0.41% 52
2025
Q3
$1.44M Sell
1,884
-120
-6% -$89.3K 0.27% 76
2025
Q2
$1.56M Sell
2,004
-6
-0.3% -$4.66K 0.31% 70
2025
Q1
$1.66M Sell
2,010
-110
-5% -$91.5K 0.37% 61
2024
Q4
$1.64M Sell
2,120
-2
-0.1% -$1.66K 0.36% 65
2024
Q3
$1.88M Buy
2,122
+179
+9% +$161K 0.36% 59
2024
Q2
$1.76M Buy
1,943
+27
+1% +$21.6K 0.45% 56
2024
Q1
$1.49M Hold
1,916
0.44% 60
2023
Q4
$1.12M Sell
1,916
-344
-15% -$201K 0.36% 71
2023
Q3
$1.21M Hold
2,260
0.44% 54
2023
Q2
$1.06M Sell
2,260
-1
-0% -$419 0.37% 67
2023
Q1
$776K Buy
2,261
+2
+0.1% +$675 0.29% 80
2022
Q4
$826K Sell
2,259
-47
-2% -$16.7K 0.33% 74
2022
Q3
$746K Hold
2,306
0.29% 79
2022
Q2
$748K Hold
2,306
0.28% 78
2022
Q1
$660K Hold
2,306
0.21% 92
2021
Q4
$637K Hold
2,306
0.19% 97
2021
Q3
$533K Hold
2,306
0.17% 98
2021
Q2
$529K Sell
2,306
-6
-0.3% -$1.21K 0.17% 100
2021
Q1
$432K Sell
2,312
-40
-2% -$7.82K 0.15% 109
2020
Q4
$397K Buy
2,352
+200
+9% +$29.9K 0.14% 104
2020
Q3
$319K Hold
2,152
0.13% 104
2020
Q2
$353K Buy
2,152
+467
+28% +$71.7K 0.17% 90
2020
Q1
$234K Hold
1,685
0.13% 104
2019
Q4
$221K Buy
+1,685
New +$195K 0.1% 130
2019
Q2
Sell
-1,685
Closed -$219K 146
2019
Q1
$219K Buy
+1,685
New +$205K 0.11% 126

Other funds holding LLY

Westover Capital Advisors's LLY Position: Q1 2026 in Review

Westover Capital Advisors increased its Eli Lilly (LLY) stake by 77% in Q1 2026, buying an estimated $1.61M and bringing the position to 3,656 shares worth $3.36M. The position accounts for 0.62% of the portfolio, ranked #40.

Westover Capital Advisors first reported a position in LLY in Q1 2019 and has held it in 27 quarters since. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Westover Capital Advisors held 3,656 shares of Eli Lilly worth $3.36M as of Q1 2026.
  • Westover Capital Advisors bought 1,585 Eli Lilly shares in Q1 2026, an estimated $1.61M.
  • Eli Lilly made up 0.62% of Westover Capital Advisors's portfolio in Q1 2026, its #40 holding.
  • Westover Capital Advisors first reported a position in Eli Lilly in Q1 2019 and has held it in 27 quarters since.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Westover Capital Advisors's 13F filing for Q1 2026, filed 5 May 2026.